Search more about…
Leadership
NOVUM SPERO d.o.o. is the rightful owner of the formula and hold the patent for the world’s first proven anti-tumor drug.
Davor Denac, Executive Director
Dinko Vukelić, Procurement manager
R&D
Our R&D team consists of highly esteemed scientists who are internationally recognized experts in the pharmaceutical and biotechnology industries.
